Breast Cancer
Phase 2 Single Arm Trial with a Safety Lead-in of Tucatinib in Combination with Doxil for the Treatment of HER2+ Metastatic Breast Cancer (BRE 381)
- Details
ClinicalTrials.gov ID:
NCT05748834
Diagnosis Type:
NA
USOR Number:
- Address
,
P: